Plexus Corp. (NASDAQ:PLXS – Get Free Report) Director Michael Schrock sold 4,000 shares of the firm’s stock in a transaction that occurred on Tuesday, August 11th. The stock was sold at an average price of $275.00, for a total transaction of $1,100,000.00. Following the transaction, the director directly owned 40,329 shares of the company’s stock, valued at approximately $11,090,475. This trade represents a 9.02% decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan.
Plexus Trading Down 2.9%
Shares of Plexus stock opened at $264.04 on Friday. Plexus Corp. has a 1 year low of $126.86 and a 1 year high of $307.06. The company has a debt-to-equity ratio of 0.06, a current ratio of 1.49 and a quick ratio of 0.72. The business has a 50 day moving average price of $272.53 and a 200 day moving average price of $240.12. The company has a market capitalization of $7.06 billion, a P/E ratio of 38.94 and a beta of 0.90.
Plexus (NASDAQ:PLXS – Get Free Report) last announced its earnings results on Wednesday, July 29th. The technology company reported $2.32 EPS for the quarter, beating analysts’ consensus estimates of $2.13 by $0.19. The firm had revenue of $1.30 billion for the quarter, compared to analysts’ expectations of $1.23 billion. Plexus had a return on equity of 12.46% and a net margin of 4.03%.Plexus’s quarterly revenue was up 28.2% on a year-over-year basis. During the same quarter in the prior year, the firm earned $1.64 EPS. Plexus has set its Q4 2026 guidance at 2.470-2.630 EPS. Sell-side analysts anticipate that Plexus Corp. will post 6.73 EPS for the current fiscal year.
Institutional Investors Weigh In On Plexus
Analyst Ratings Changes
A number of analysts recently commented on PLXS shares. Sidoti upgraded Plexus from a “neutral” rating to a “buy” rating and set a $308.00 price objective for the company in a research report on Friday, July 31st. Needham & Company LLC upped their target price on shares of Plexus from $285.00 to $310.00 and gave the company a “buy” rating in a report on Monday, June 1st. Wall Street Zen raised shares of Plexus from a “hold” rating to a “buy” rating in a research note on Saturday, May 2nd. Weiss Ratings downgraded shares of Plexus from a “buy (b)” rating to a “buy (b-)” rating in a report on Tuesday. Finally, Zacks Research raised shares of Plexus from a “hold” rating to a “strong-buy” rating in a research report on Tuesday. One equities research analyst has rated the stock with a Strong Buy rating and six have issued a Buy rating to the stock. According to data from MarketBeat.com, Plexus has a consensus rating of “Buy” and an average target price of $273.00.
View Our Latest Stock Analysis on PLXS
Plexus Company Profile
Plexus Corp. (NASDAQ: PLXS) is a global provider of electronics manufacturing services (EMS) and precision engineered electronics solutions. Headquartered in Neenah, Wisconsin, the company partners with original equipment manufacturers across industries such as medical, industrial, aerospace and defense, computing, and communications. Plexus offers a full suite of services that span new product introduction, product lifecycle management, supply chain management, printed circuit board assembly, system integration, and aftermarket support.
Founded in 1979, Plexus has grown from a regional electronics assembler into a multinational organization with manufacturing and engineering centers across North America, Europe, and Asia.
See Also
- Five stocks we like better than Plexus
- Asian Market Circuit Breakers Hit Stocks, Not AI Demand
- Riot Platforms Re-Wires the Ledger for a $9B AI Power Play
- Nebius Just Exploded 34% on Blowout Earnings—Is It Time to Buy?
- Joby’s Defense Pivot Accelerates With $500M Resonant Sciences Deal
Receive News & Ratings for Plexus Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Plexus and related companies with MarketBeat.com's FREE daily email newsletter.
